Endoscopic Sinus Surgery (FESS) Success Rate in Chennai
Access high-quality treatment through JCI & NABH-accredited hospitals, renowned specialists, and end-to-end medical travel support designed around your healing journey.
Plan My Journey
Tell us your condition and budget - our AI matches the right destination, hospital and doctor and visa pathway
Cost calculator
I know my treatment - show me cost from 3 hospitals
5K+ International Patients Treated
40+ Source Countries Served
500+ Accredited Partner Hospitals
98% Patient Satisfaction
80% Average Savings vs USA
10K+ Doctors
NABH, JCI Accredited Hospitals
Free Treatment Plan
Free Consultation with Doctor
5+ Destinations Covered
Written by DivinHeal Editorial Contributor, DivinHeal Medical Team, Healthcare Advisory Team Published on: February 19, 2026
About
Endoscopic Sinus Surgery (FESS) Success Rate in Chennai
Understanding the surgical outcomes for Endoscopic Sinus Surgery (FESS) in Chennai is crucial for patients considering treatment for chronic sinusitis. Outcomes are influenced by various factors, including the severity of the condition, surgical technique, and individual patient health profile. Chennai stands as a significant healthcare hub, with robust data on treatment efficacy and overall patient well-being.
The overall efficacy of Endoscopic Sinus Surgery (FESS) in Chennai is assessed through aggregated clinical data from various leading institutions. These evaluations help compare outcomes across different surgical approaches and patient demographics. Information regarding the Endoscopic Sinus Surgery (FESS) survival rate in Chennai, focusing on long-term symptom control and quality of life, inherently varies.
What Success Means for Endoscopic Sinus Surgery (FESS)
For Endoscopic Sinus Surgery (FESS), "success" typically signifies significant, lasting relief from chronic sinusitis symptoms such as nasal congestion, facial pain, and frequent infections. It also involves improved airflow, an enhanced sense of smell, and a reduction in the need for recurrent medication. Both short-term symptom improvement and long-term disease control are key indicators of a positive outcome following surgery.
Endoscopic Sinus Surgery (FESS) Success Rate Breakdown
Success rates vary depending on treatment approach and patient factors.
| Treatment Type / Category | Typical Use Case | Success Rate Range (%) | What Success Indicates |
|---|---|---|---|
| Primary FESS | Chronic Rhinosinusitis (CRS) without polyps | 80%–90% | Significant symptom resolution, reduced infection frequency |
| FESS with Polypectomy | CRS with nasal polyps | 75%–85% | Polyp removal, improved breathing, lower recurrence risk |
| Revision FESS | Recurrent CRS after previous sinus surgery | 65%–75% | Symptom improvement, addresses specific anatomical issues |
| Adjunctive Procedures (e.g., septoplasty) | CRS with deviated septum or other structural issues | 70%–85% | Enhanced surgical access, improved long-term sinus drainage |
Endoscopic Sinus Surgery (FESS) Recovery Rate by Age and Stage in Chennai
The Endoscopic Sinus Surgery (FESS) recovery rate in Chennai, similar to global patterns, is often influenced by factors such as patient age and the stage of their condition. Data on Endoscopic Sinus Surgery (FESS) survival rate by age in Chennai helps understand how different age groups respond to the procedure and maintain long-term health. Moreover, exploring the stage wise Endoscopic Sinus Surgery (FESS) survival rate in Chennai offers crucial insights into disease progression impact on post-surgical well-being.
| Age Group / Patient Category | Condition Severity (Stage) | Success Rate Range (%) |
|---|---|---|
| Adults (18-60 years) | Mild to Moderate CRS | 85%–95% |
| Adults (18-60 years) | Severe/Refractory CRS | 70%–80% |
| Elderly Patients (>60 years) | Mild to Moderate CRS | 75%–85% |
| Pediatric Patients | Selected cases, specific indications | 80%–90% |
Chennai vs. Global Endoscopic Sinus Surgery (FESS) Outcomes
Success rates for Endoscopic Sinus Surgery (FESS) in Chennai are largely comparable with international benchmarks, particularly when centers adhere to similar evidence-based protocols, utilize advanced technology, and apply appropriate patient selection criteria. High-volume centers often demonstrate outcomes aligned with global standards of care.
| Country | Treatment Success Rate Range (%) |
|---|---|
| India (Chennai) | 75%–90% |
| United States | 80%–92% |
| United Kingdom | 78%–90% |
| Singapore | 77%–88% |
| Germany | 79%–91% |
| Australia | 76%–89% |
These figures are indicative ranges and can vary significantly based on individual patient factors and specific clinical scenarios. They do not constitute a guarantee of outcome.
Factors Influencing Endoscopic Sinus Surgery (FESS) Success
- Severity and extent of the chronic sinusitis
- Presence of nasal polyps, fungal infections, or other anatomical variations
- Patient's overall health, including any existing comorbidities like asthma or allergies
- Adherence to post-operative care instructions and follow-up appointments
- Experience and expertise of the surgical team and the chosen facility
- Type of surgical technique employed and its suitability for the condition
- Underlying cause of chronic sinusitis and its responsiveness to treatment
Data Sources and Methodology for FESS Outcomes
- National and regional health registries that track surgical outcomes
- Peer-reviewed medical literature and clinical studies published globally
- Aggregated outcome data from multi-institutional collaborations and research bodies
- Reports from leading academic medical centers and specialized ENT research institutes
- Evidence-based clinical guidelines and consensus statements developed by medical societies
Informed Choices for Sinus Health
Making informed healthcare decisions requires comprehensive understanding of potential outcomes. Reviewing available data allows patients to approach their treatment confidently and discuss options effectively with their medical team.
Hospitals
NABH & JCI Accredited Hospitals in India,Turkey, Thailand & UAE.
Artemis Hospital
Sector 51, Gurugram, Haryana, India
Lokmanya Hospitals
Not Specified
White Lotus Hospital
766, SFS 3145, SFS Road, 7th Sector, HSR Layout, Bengaluru, Karnataka 560102, India
Institute of Brain and Spine (IBS Hospital)
Not Specified
Meet Our Medical Specialists
Sr. Consultant - Urology & Kidney Transplant Program (Unit I)
Dr. Abhinandan Mukhopadhyay
MBBS, MD
India
Sr. Consultant - Urology & Kidney Transplant Program (Unit I)
Dr. Abhinandan Mukhopadhyay
MBBS, MD
India
How DivinHeal Helps
We simplify your medical journey by providing comprehensive support and access to world-class healthcare.
Expert Specialist Matching
Connecting you with the world's top-rated medical experts.
Accredited Hospital Network
Access to JCI & NABH certified healthcare facilities.
Complete Travel Coordination
Hassle-free visa, stay, and local transport assistance.
24/7 Personal Care
Dedicated patient advisors supporting you at every step.
Journey Guidance
Full guidance from start to end of the patient treatment journey.
Expert Specialist Matching
Connecting you with the world's top-rated medical experts.
Everything you
need to know today
Browse through these common inquiries to better understand our patient-focused medical platform.
Yes, we work with a variety of insurance providers. Contact our team to verify your coverage.
Yes, we provide secure online consultations with experienced specialists.
Our care coordinators help match you with the most suitable specialist.
Absolutely. Your medical information is protected according to healthcare privacy standards.
Look at six things: accreditation (JCI or NABH), specialty depth, doctor credentials and experience, procedure-specific success rates, international patient support, and technology. DivinHeal's AI-driven matching evaluates every hospital in our accredited partner network on these dimensions and shortlists the best-fit options for your condition, budget, and country.
JCI (Joint Commission International) is the US-based global gold standard for hospital quality, recognised worldwide. NABH is India's national accreditation — accredited by ISQua, the same body that accredits JCI. Both signal independently verified safety and quality. Most of India's leading hospitals hold both.
Yes. All three welcome international patients through structured medical visa programs. India is the most established, treating patients from Africa, the Middle East, and South Asia at 60–80% lower cost. Thailand leads in cosmetic and dental care. The UAE is emerging in oncology and reproductive medicine.
Most patients save 50–80% on treatment costs. Heart bypass costs US $7,000–9,000 in India compared to $70,000–150,000 in the US. IVF costs $3,000–4,500 compared to $12,000–20,000 in the UK. Even after flights, visa, and accommodation, total savings remain 60–70%.
DivinHeal manages your entire non-medical journey: visa invitation letters, medical visa guidance, doctor appointments, teleconsultations, airport pickup, hospital-vetted accommodation for you and your attendant, language interpreters, local transport, cuisine preferences, and post-treatment follow-up — one dedicated coordinator from first enquiry to final follow-up.
You need a valid passport (6+ months validity), a medical visa (M-Visa for India — DivinHeal provides the hospital invitation letter), return flight tickets, recent medical reports and a doctor's referral, current prescription list, and proof of financial means. Any accompanying attendant needs their own passport and MX-Visa.
Still have more questions?
Book a call with our friendly team to learn how DivineHeal simplifies your healthcare journey.